Who This Applies To
Women roughly ages 18–35 with active menstrual cycles, including those trying to conceive, those with polycystic ovary syndrome (PCOS), and those with regular hormonal fluctuations.
The Core Challenge
Fasting triggers a physiological stress response. When the body perceives caloric scarcity, the hypothalamus-pituitary-adrenal (HPA) axis activates, releasing cortisol. Elevated cortisol suppresses the release of luteinizing hormone (LH) — the hormone that triggers ovulation — and disrupts the signaling cascade controlling the entire menstrual cycle. This means that poorly timed or excessively long fasting can interfere with ovulation, cycle regularity, and fertility.
A 2025 review in Nutrition Reviews confirmed that more than 30% of reproductive-age women are overweight or obese, and that intermittent fasting — including alternate day fasting, time restricted eating, and 5:2 day fasting — has demonstrated benefits for obesity-related metabolic diseases in this population, while also acknowledging that the approach is a “double-edged sword” with reproductive implications.
What the Research Shows: PCOS
The most robust evidence for IF in reproductive-age women comes from research on polycystic ovary syndrome (PCOS – newly termed PMOS), an endocrine disorder affecting 8–13% of reproductive-age women worldwide and characterized by excess androgens, insulin resistance, and irregular cycles.
A 2025 systematic review, found that time-restricted feeding (TRF) interventions produced significant improvements in menstrual regularity, with 33–40% of participants reporting normalized cycles. Key hormonal outcomes included a 9% reduction in total testosterone, a 26% reduction in the free androgens, reductions in anti-Müllerian hormone and LH, and a significant increase in sex hormone-binding globulin (SHBG) — all markers of improved reproductive health.
A separate 2025 meta-analysis drawing on six studies and 347 women (174 IF, 173 control) found that the LH/FSH ratio dropped by approximately 21%, fasting insulin decreased significantly, and 64–72% of participants on IF reported better menstrual cycles and improved ovulation.
A University of Illinois Chicago review in Nutrients further found that the hormonal benefits of fasting in premenopausal women were most pronounced when eating was confined to earlier in the day — specifically, consuming all food before 4 PM.
The Menstrual Cycle and Fasting Windows
Research supports aligning fasting length with the phase of the menstrual cycle:
| Cycle Phase | Days | Recommended Fast Length | Rationale |
| Menstrual | Days 1–5 | 12–14 hours | Gentle; avoid longer fasts during bleeding |
| Follicular | Days 6–14 | Up to 16 hours | Estrogen rising; best window for longer fasts |
| Ovulatory | ~Day 14 | 14–16 hours, listen to hunger | Estrogen peaks; stress tolerance is high |
| Luteal | Days 15–28 | 12–13 hours max | Progesterone dominant; cortisol sensitivity is higher |
Extended fasting is particularly contraindicated in the late luteal phase (days 19–28). Because fasting is a form of mild stress and cortisol suppresses progesterone, extending fasting windows during this phase can deplete the very hormones needed for a healthy luteal phase.
Cautions for Reproductive-Age Women
-
- Women with a history of eating disorders should be carefully screened before beginning any fasting protocol, as restriction can trigger or exacerbate disordered eating patterns.
- Fasting is not recommended during pregnancy or active attempts to conceive.
- Adolescents (under 18) face heightened risks for long fasting
Conclusion for Fasting in Reproductive Aged Women
The best supported protocol is based on days of the cycle. Time restricted eating 16:8 confined to the follicular phase (days 6-14 of menstrual cycle) or adjusted to a gentler 12–14 hours during the luteal phase. An early eating window (e.g., 7 AM–3 PM or 8 AM–4 PM) appears to be more beneficial than a late-day window.
A Note on Research Limitations
The evidence base for women-specific fasting research, while growing rapidly, still carries important caveats. Many studies have small sample sizes, short durations (often 6–12 weeks), and focus predominantly on women with obesity — limiting generalizability to normal-weight or lean women. Very few studies have followed women across multiple years, meaning long-term effects on bone density, cognitive health, and reproductive function remain areas of active investigation. Women considering intermittent fasting, particularly those with existing hormonal conditions, metabolic disease, or medications, should consult a healthcare provider before beginning.
